equityflowunderstand the flow and follow it
EquityFlow › Companies › Link Therapeutics

Link Therapeutics

Biotech · JP

Autoantibody-targeting therapies for autoimmune diseases

In the network

Shares the most investors with (number = shared investors):
Alumnote 2

Funding history

DateRoundAmount
Jul 2025Series B
Japanese biotech Link Therapeutics raised a JPY 850m Series B (Itochu Technology Ventures, Kyoto University Innovation Capital, MUFG Medical Fund, SMBC Venture Capital, Kobe University Capital).
$5.5M

Investors

Tap an investor to see what else they have backed.

Itochu Technology VenturesKyoto University Innovation CapitalMUFG Medical FundSMBC Venture Capital

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in JP

PayPayRapidusMWAracanSmart CraftHerLifeLabTokenzDubGuildDJ InsightSnack TechnologiesNekonomeLinQ

Other companies at Series B stage

0x Labs11x.ai1K Kirana1X Technologies1plusX3Commas3SC4baseCare4screen8fig9finACALL
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.